Trisenox and haemoglobin decreased Patient Reports February 13, 2012

Trisenox Side Effects Report #4765977-3
Trisenox side effect was reported by a Physician from UNITED STATES on Aug 25, 2005. Female patient, 79 years of age, weighting 123.5 lb, was diagnosed with myelodysplastic syndrome and was treated with Trisenox. After drug was administered, patient experienced the following side effects: abdominal distension, asthenia, blood potassium increased, fatigue, haematocrit decreased, haemoglobin decreased, metabolic disorder , nephrolithiasis, pitting oedema. Trisenox dosage: 12.5 MG Q72HR INTRAVENOUS DRIP. During the same period patient was treated with POLYSTYRENE SULFONATE, AMBIEN, LOPRESSOR, SULFAMETHOXAZOLE, THALOMID, ASCORBIC ACID, DECADRON, FOLIC ACID. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #4616617-5
Trisenox side effect was reported by a Consumer or non-health professional from on Feb 21, 2005. Male patient, 74 years of age, was diagnosed with myelodysplastic syndrome and was treated with Trisenox. After drug was administered, patient experienced the following side effects: ascites, blood iron increased, depressed level of consciousness, ecchymosis, haematochezia, haematocrit decreased, haemodialysis, haemoglobin decreased, heart rate increased. Trisenox dosage: 21 MG (0.25 M G/KG, TWICE WEEKLY) IVI. During the same period patient was treated with THALIDOMIDE, FILGRASTIM, EPOGEN, PYRIDOXINE, PROPRANOLOL, GLIPIZIDE, FAMOTIDINE. Patient was hospitalized. Patient died.

Trisenox Side Effects Report #4816273-7
Trisenox side effect was reported by a Physician from UNITED STATES on Oct 14, 2005. Male patient, 68 years of age, was diagnosed with myelodysplastic syndrome and was treated with Trisenox. After drug was administered, patient experienced the following side effects: cough, crepitations, dyspnoea exertional, haemoglobin decreased, leukopenia, oedema peripheral, petechiae, pitting oedema, platelet count decreased. Trisenox dosage: unknown. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #4831313-7
Trisenox side effect was reported by a Physician from UNITED STATES on Nov 01, 2005. Male patient, 72 years of age, weighting 206.0 lb, was diagnosed with multiple myeloma  and was treated with Trisenox. After drug was administered, patient experienced the following side effects: asthenia, atrial fibrillation , cardiac failure congestive, dyspnoea, electrolyte imbalance, haemoglobin decreased, hypoalbuminaemia, hyponatraemia, hypophosphataemia. Trisenox dosage: 24 MG QD INTRAVENOUS DRIP. During the same period patient was treated with THALOMID, ZOMETA, PROCRIT, PLAVIX, ATENOLOL, NIACIN, POTASSIUM CHLORIDE, ACYCLOVIR. Patient was hospitalized. Patient recovered.


Trisenox Side Effects Report #4842214-2
Trisenox side effect was reported by a Physician from UNITED STATES on Nov 14, 2005. Male patient, 72 years of age, weighting 206.0 lb, was diagnosed with multiple myeloma  and was treated with Trisenox. After drug was administered, patient experienced the following side effects: asthenia, atrial fibrillation , cardiac failure congestive, electrolyte imbalance, haemoglobin decreased, hypoalbuminaemia, hyponatraemia, hypophosphataemia, malignant neoplasm progression. Trisenox dosage: 24 MG QD INTRAVENOUS DRIP. During the same period patient was treated with THALOMID, ZOMETA, PROCRIT, PLAVIX, ATENOLOL, NIACIN, POTASSIUM CHLORIDE, ACYCLOVIR. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #4568437-8
Trisenox side effect was reported by a Consumer or non-health professional from on Jan 11, 2005. Male patient, 67 years of age, was diagnosed with multiple myeloma  and was treated with Trisenox. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, heart rate increased, infection , light chain analysis increased, oral mucosal blistering, pyrexia, rash maculo-papular, rash pruritic. Trisenox dosage: 20 MG IVI. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5515367-0
Trisenox side effect was reported by a Physician from UNITED STATES on Oct 25, 2007. Female patient, weighting 142.0 lb, was diagnosed with multiple myeloma  and was treated with Trisenox. After drug was administered, patient experienced the following side effects: bacteraemia, blood magnesium increased, coronary artery disease , enterococcal infection, febrile neutropenia, haematocrit decreased, haemoglobin decreased, heart rate increased, hypotension. Trisenox dosage: 0.25 MG/KG UNK INTRAVENOUS. During the same period patient was treated with HYDROMORPHONE, LOPERAMIDE, HEPARIN, CHLORIDE, LANOLIN, LORAZEPAM, MORPHINE, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5401991-2
Trisenox side effect was reported by a Physician from JAPAN on July 17, 2007. Female patient, 86 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: arrhythmia , haemoglobin decreased, hypocalcaemia, neutrophil count decreased, ventricular extrasystoles. Trisenox dosage: 6.105 MG QD INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, PREDNISOLONE ACETATE, METHOTREXATE, CALCIUM GLUCONATE. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5047197-0
Trisenox side effect was reported by a Physician from JAPAN on June 21, 2006. Female patient, 84 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: c-reactive protein increased, disseminated intravascular coagulation, haemoglobin decreased, hypokalaemia, malignant neoplasm progression, platelet count decreased, renal failure, respiratory failure. Trisenox dosage: 4.1 MG QD, INTRAVENOUS DRIP. During the same period patient was treated with FUROSEMIDE, MEXILETINE HYDROCHLORIDE, NIFEDIPINE, NIZATIDINE, INSULIN. Patient was hospitalized. Patient recovered.


Trisenox Side Effects Report #5029162-2
Trisenox side effect was reported by a Physician from JAPAN on May 31, 2006. Female patient, 84 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia, c-reactive protein increased, haemoglobin decreased, hypokalaemia, malignant neoplasm progression, platelet count decreased, white blood cell count decreased. Trisenox dosage: 4.1 MG QD INTRAVENOUS DRIP. During the same period patient was treated with FUROSEMIDE, MEXILETINE HYDROCHLORIDE, NIFEDIPINE, NIZATIDINE, INSULIN. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5361222-9
Trisenox side effect was reported by a Physician from JAPAN on June 04, 2007. Male patient, 73 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: blood pressure systolic decreased, bone marrow failure, c-reactive protein increased, haemoglobin decreased, neutrophil count decreased, platelet count decreased, pleural effusion, respiratory arrest, urine output decreased. Trisenox dosage: 9 MG QD INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, METHOTREXATE, ARBEKACIN SULPHATE, ARBEKACIN SULPHATE, ARBEKACIN SULPHATE, PREDNISOLONE SUCCINATE, NAFAMOSTAT, LENOGRASTIM. Patient died on 05/06/2007.

Trisenox Side Effects Report #4618289-2
Trisenox side effect was reported by a Physician from on Mar 02, 2005. Female patient, 72 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, condition aggravated, gamma-glutamyltransferase increased, haemoglobin decreased, hepatic function abnormal. Trisenox dosage: unknown. Patient recovered.

Trisenox Side Effects Report #4686792-5
Trisenox side effect was reported by a Physician from on May 08, 2005. Female patient, 72 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, haemoglobin decreased, hepatic function abnormal. Trisenox dosage: 4.8 MG (4.8 MG) INTRAVENOUS. Patient recovered.

Trisenox Side Effects Report #4680715-0
Trisenox side effect was reported by a Physician from on May 13, 2005. Male patient, 65 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: blood urea increased, haemoglobin decreased, protein total decreased, small intestinal haemorrhage. Trisenox dosage: unknown. During the same period patient was treated with ASPIRIN. Patient recovered.


Trisenox Side Effects Report #4692312-1
Trisenox side effect was reported by a Physician from on May 25, 2005. Male patient, 65 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: blood urea increased, catheter related infection, haemoglobin decreased, heart rate increased, protein total decreased, small intestinal haemorrhage. Trisenox dosage: 9.6 MG (9.6 MG), IVI. During the same period patient was treated with ASPIRIN. Patient recovered.

Trisenox Side Effects Report #4701613-X
Trisenox side effect was reported by a Physician from on June 10, 2005. Male patient, 65 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: atrial fibrillation , blood urea increased, catheter related infection, haemoglobin decreased, protein total decreased, small intestinal haemorrhage, ureteric stenosis. Trisenox dosage: 9.6 MG (9.6 MG), IVI. During the same period patient was treated with ASPIRIN. Patient recovered.

Trisenox Side Effects Report #4732841-5
Trisenox side effect was reported by a Physician from JAPAN on July 12, 2005. Female patient, 60 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: condition aggravated, haemoglobin decreased, leukopenia, neutropenia. Trisenox dosage: 8.85 MG (8.85 MG), IVI. Patient recovered.

Trisenox Side Effects Report #4848089-X
Trisenox side effect was reported by a Physician from JAPAN on Nov 21, 2005. Female patient, 60 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, haemoglobin decreased, herpes zoster, leukopenia, neutropenia, neutrophil count decreased, white blood cell count decreased. Trisenox dosage: 8.85 MG QD INTRAVENOUS DRIP. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5179503-0
Trisenox side effect was reported by a Physician from JAPAN on Nov 29, 2006. Female patient, 53 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, electrocardiogram qt prolonged, haemoglobin decreased, hepatic function abnormal, red blood cell count decreased, white blood cell count decreased. Trisenox dosage: 7.35 MG QD INTRAVENOUS DRIP. Patient recovered.


Trisenox Side Effects Report #4853590-9
Trisenox side effect was reported by a Physician from JAPAN on Nov 30, 2005. Male patient, 48 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: enteritis infectious, gastrointestinal disorder, haemoglobin decreased, hyperplasia, ileus, white blood cell count decreased. Trisenox dosage: 8.4 MG QD INTRAVENOUS. During the same period patient was treated with CHLORPROMAZINE, TRIHEXYPHENIDYL HYDROCHLORIDE, ZOTEPINE, FLUNITRAZEPAM, FAMOTIDINE, FLUCONAZOLE, GABEXATE MESILATE. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #6088508-7
Trisenox side effect was reported by a Physician from JAPAN on Feb 09, 2009. Male patient, 46 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, haemoglobin decreased, hepatic function abnormal, platelet count decreased, white blood cell count decreased. Trisenox dosage: 7.65 MG QD; INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, METHOTREXATE, DEXAMETHASONE PHOSPHATE, FILGRASTIM. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #6108579-9
Trisenox side effect was reported by a Health Professional from JAPAN on Feb 19, 2009. Male patient, 46 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, haemoglobin decreased, hepatic function abnormal, platelet count decreased, white blood cell count decreased. Trisenox dosage: 7.65 MG QD INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, METHOTREXATE, DEXAMETHASONE PHOSPHATE, FILGRASTIM. Patient was hospitalized and became disabled. Patient recovered.

Trisenox Side Effects Report #5574034-8
Trisenox side effect was reported by a Physician from JAPAN on Dec 14, 2007. Male patient, 28 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, electrocardiogram qt prolonged, gamma-glutamyltransferase increased, haemoglobin decreased, tonsillitis. Trisenox dosage: 12 MG QD; INTRAVENOUS DRIP. During the same period patient was treated with DALTEPARIN, SULFAMETHOXAZOLE AND TRIMETHOPRIM, FLUCONAZOLE, OMEPRAZOLE, ROXATIDINE ACETATE, FAMOTIDINE. Patient recovered.

Trisenox Side Effects Report #5580740-1
Trisenox side effect was reported by a Physician from JAPAN on Dec 06, 2007. Male patient, 28 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, c-reactive protein increased, electrocardiogram qt prolonged, gamma-glutamyltransferase increased, haemoglobin decreased, hepatic function abnormal, tonsillitis. Trisenox dosage: 12 MG QD INTRAVENOUS DRIP. During the same period patient was treated with DALTEPARIN, SULFAMETHOXAZOLE AND TRIMETHOPRIM, FLUCONAZOLE, OMEPRAZOLE, ROXATIDINE ACETATE, FAMOTIDINE. Patient was hospitalized. Patient recovered.


Trisenox Side Effects Report #5497267-8
Trisenox side effect was reported by a Physician from JAPAN on Oct 10, 2007. Female patient, 27 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia differentiation syndrome, alanine aminotransferase increased, aspartate aminotransferase increased, electrocardiogram qt prolonged, haemoglobin decreased, hepatic function abnormal, hypokalaemia, leukocytosis, platelet count decreased. Trisenox dosage: 7.8 MG QD INTRAVENOUS DRIP. During the same period patient was treated with ELECTROLYTE, IDARUBICIN, PANIPENEM, AMIKACIN SULPHATE, MICAFUNGIN, ABREKACIN SULPHATE, MEROPENEM HYDRATE. Patient recovered.

Trisenox Side Effects Report #5525457-4
Trisenox side effect was reported by a Physician from JAPAN on Nov 05, 2007. Female patient, 27 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia differentiation syndrome, alanine aminotransferase increased, aspartate aminotransferase increased, electrocardiogram qt prolonged, haemoglobin decreased, hepatic function abnormal, hypokalaemia, leukocytosis, platelet count decreased. Trisenox dosage: 7.8 MG QD INTRAVENOUS DRIP. During the same period patient was treated with IDARUBICIN, PANIPENEM, AMIKACIN SULPHATE, MICAFUNGIN, ARBEKACIN SULPHATE, MEROPENEM HYDRATE. Patient recovered.

Trisenox Side Effects Report #6108673-2
Trisenox side effect was reported by a Health Professional from JAPAN on Feb 23, 2009. Male patient, 25 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: cardiac tamponade, chest pain , haemoglobin decreased, hepatic enzyme increased, melaena, pericardial effusion, pleural effusion. Trisenox dosage: 10 MG QD INTRAVENOUS DRIP. During the same period patient was treated with PHENYTOIN, TOSUFLOXACIN TOSILATE, OXETHAZAINE, LANSOPRAZOLE, VALPROATE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, ALENDRONATE, BROTIZOLAM. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #6141226-9
Trisenox side effect was reported by a Health Professional from JAPAN on Mar 19, 2009. Male patient, 25 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: cardiac tamponade, cardiovascular insufficiency, gastrointestinal haemorrhage, haemoglobin decreased, hepatic enzyme increased, pericardial effusion, pleural effusion. Trisenox dosage: 10 MG (10 MG, 1 IN 1 D), INTRAVENOUS DRIP. During the same period patient was treated with PHENYTOIN, TOSULFOXACIN TOSILATE, OXETHAZAINE, LANSOPRAZOLE, VALPROATE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, ALENDRONATE HYDRATE, BROTIZOLAM. Patient was hospitalized. Patient recovered.